A comparison of the efficacy of transforaminal Triamcinolone and Magnesium sulfate injection in chronic low back pain.

Not Applicable

Recruiting

Conditions: chronic low back pain.
low back pain

Registration Number: IRCT201306307984N10

Lead Sponsor: Vice Chancellor for Research and Technology of Iran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 30

Inclusion Criteria

1.Age 20-70 years
2.Pain at least 6 weeks
3.Evidence of Nerve root involvement as disc bulging and/or foraminal stenosis in CT/MRI
4.VAS > 4
5.ASA class I, II
6.Patients’ Informed consent

Exclusion criteria:

1.Patients’ with coagulopathy
2.Infection in injection site as Herpetic diseases
3.Anatomical and congenital spine deformity as severe scoliosis
4.Surgical history instrument insertion
5.Psychological severe disorders
6.History of harmful reaction to local anesthetic and steroid.
7.Patients with motor deficit or progressive neural defect.
8.Cancer
9.Neural foramen radiological access difficulty
10. Substance abuse
11. HIV
12. Acute trauma
13. Cauda Equina syndrome
14. More than 3 level abnormalities
15.Absence of Inevitable radicular pain

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ow back pain. Timepoint: Before injection,two weeks,1,3 and 6 month after intervention. Method of measurement: pain score measured with visual analogue scale in Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Patient performance is based on Oswestry Disability Index, and degree of Leg Raising is based on Straight Leg Raising Test, and possible complications will be recorded. Timepoint: Before injection, two weeks, 1,3 and 6 moth after intervention. Method of measurement: Questionnaire.